No paralogue variants have been mapped to residue 84 for KCNQ1.
KCNQ1 | -----APPASPAAPAAPPVASDL---GPRP>P<VSL------DPRVSIYSTRRPVLARTH--- | 105 |
KCNQ2 | ----------RGSILS----------KPRA>G<G--AGAGK-PPKRNAFYRK----------- | 76 |
KCNQ3 | ---QR---R----TPQ----------GIGL>-<LAKTPLSRPVKRNNAKYRR----------- | 106 |
KCNQ4 | ---L------PPGAPLP---------GPGS>G<SGSACGQR-SSAAHKRYRR----------- | 82 |
KCNQ5 | ---LRESRRGKQGARMS---------LLGK>P<L-SYTSSQ-SCRRNVKYRR----------- | 110 |
KCNA1 | YYQSGGRLRRPVNVPLDMFSEEIKFYELGE>E<AME----K--FREDEGF------------- | 136 |
KCNA10 | YYQSGGKIRRPANVPIDIFADEISFYELGS>E<AMD----Q--FREDEGF------------- | 185 |
KCNA2 | YYQSGGRLRRPVNVPLDIFSEEIRFYELGE>E<AME----M--FREDEGY------------- | 132 |
KCNA3 | YYQSGGRIRRPVNVPIDIFSEEIRFYQLGE>E<AME----K--FREDEGF------------- | 203 |
KCNA4 | YYQSGGRLKRPVNVPFDIFTEEVKFYQLGE>E<ALL----K--FREDEGF------------- | 275 |
KCNA5 | YYQSGGRLRRPVNVSLDVFADEIRFYQLGD>E<AME----R--FREDEGF------------- | 219 |
KCNA6 | YYQSGGRLRRPVNVPLDIFLEEIRFYQLGD>E<ALA----A--FREDEGC------------- | 140 |
KCNA7 | YYQSGGRLRRPAHVPLDVFLEEVAFYGLGA>A<ALA----R--LREDEGC------------- | 112 |
KCNB1 | FYRT-GRLHMMEEMCALSFSQELDYWGIDE>I<YLE----S--CCQARYHQKKEQMNEELKRE | 151 |
KCNB2 | FYRT-GKLHMMEEMCALSFGQELDYWGIDE>I<YLE----S--CCQARYHQKKEQMNEELRRE | 155 |
KCNC1 | YYRT-GKLHCPADVCGPLYEEELAFWGIDE>T<DVE----P--CCWMTYRQHRDAEEALDSFG | 123 |
KCNC2 | YYRT-GKLHCPADVCGPLFEEELAFWGIDE>T<DVE----P--CCWMTYRQHRDAEEALDIFE | 170 |
KCNC3 | YYRT-GKLHCPADVCGPLFEEELGFWGIDE>T<DVE----A--CCWMTYRQHRDAEEALDSFE | 203 |
KCNC4 | YYRT-GKLHCPADVCGPLFEEELTFWGIDE>T<DVE----P--CCWMTYRQHRDAEEALDIFE | 162 |
KCND1 | FYRT-GRLHCPRQECIQAFDEELAFYGLVP>E<LVG----D--CCLEEYRDRKKENAERLAED | 150 |
KCND2 | FYRT-GKLHYPRHECISAYDEELAFFGLIP>E<IIG----D--CCYEEYKDRRRENAERLQDD | 151 |
KCND3 | FYRT-GKLHYPRYECISAYDDELAFYGILP>E<IIG----D--CCYEEYKDRKRENAERLMDD | 150 |
KCNF1 | VYYF-GEVHMKKGICPICFKNEMDFWKVDL>K<FLD----D--CCKSHLSEKREELEEIARRV | 145 |
KCNG1 | FLRA-GKLRLLREMCALSFQEELLYWGIAE>D<HLD----G--CCKRRYLQKIEEFAEMVERE | 183 |
KCNG2 | LLRA-GKLRLLRGPCALAFRDELAYWGIDE>A<RLE----R--CCLRRLRRREEEAAEARAGP | 137 |
KCNG3 | YVRGHGKLRFAPRMCELSFYNEMIYWGLEG>A<HLE----Y--CCQRRLDDRMSDTYTFYSAD | 130 |
KCNG4 | FLAA-GKLVLLQEMCALSFQEELAYWGIEE>A<HLE----R--CCLRKLLRKLEELEELAKLH | 179 |
KCNS1 | FYRT-GHLHVLDELCVFAFGQEADYWGLGE>N<ALA----A--CCRARYLERRLTQ-PHAWDE | 169 |
KCNS2 | FYHT-GKLHVMAELCVFSFSQEIEYWGINE>F<FID----S--CCSYSYHGRKVEPEQEKWDE | 137 |
KCNS3 | FYYT-GKLHVMEELCVFSFCQEIEYWGINE>L<FID----S--CCSNRYQERKEENHEKDWDQ | 135 |
KCNV1 | YYRT-GRLHVMEQLCALSFLQEIQYWGIDE>L<SID----S--CCRDRYFRRKE-LSETLDFK | 168 |
KCNV2 | FYLS-GVLLVLDGLCPRRFLEELGYWGVRL>K<YTP----R--CCRICFEERRDELSERLKIQ | 217 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.Pro84Arg | c.251C>G | Unknown | SIFT: Polyphen: |